Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5089586016 | Product containing precisely levonorgestrel 13.5 milligram/1 each prolonged-release intrauterine drug delivery system (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5089731015 | Levonorgestrel 13.5 mg prolonged-release intrauterine drug delivery system | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely levonorgestrel 13.5 milligram/1 each prolonged-release intrauterine drug delivery system (clinical drug) | Is a | Product containing only levonorgestrel in intrauterine dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely levonorgestrel 13.5 milligram/1 each prolonged-release intrauterine drug delivery system (clinical drug) | Has manufactured dose form | Prolonged-release intrauterine drug delivery system | false | Inferred relationship | Some | ||
| Product containing precisely levonorgestrel 13.5 milligram/1 each prolonged-release intrauterine drug delivery system (clinical drug) | Has unit of presentation | System | true | Inferred relationship | Some | ||
| Product containing precisely levonorgestrel 13.5 milligram/1 each prolonged-release intrauterine drug delivery system (clinical drug) | Plays role | Contraceptive therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely levonorgestrel 13.5 milligram/1 each prolonged-release intrauterine drug delivery system (clinical drug) | Has precise active ingredient | Levonorgestrel | true | Inferred relationship | Some | 1 | |
| Product containing precisely levonorgestrel 13.5 milligram/1 each prolonged-release intrauterine drug delivery system (clinical drug) | Has basis of strength substance (attribute) | Levonorgestrel | true | Inferred relationship | Some | 1 | |
| Product containing precisely levonorgestrel 13.5 milligram/1 each prolonged-release intrauterine drug delivery system (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely levonorgestrel 13.5 milligram/1 each prolonged-release intrauterine drug delivery system (clinical drug) | Has presentation strength denominator unit (attribute) | System | true | Inferred relationship | Some | 1 | |
| Product containing precisely levonorgestrel 13.5 milligram/1 each prolonged-release intrauterine drug delivery system (clinical drug) | Has manufactured dose form | Prolonged-release intrauterine delivery system (dose form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR